Jean-Philippe Adam

12PUBLICATIONS
7CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Clinical midwifery
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Jul 25, 2024
Hypokalemia, hypomagnesemia, and hyponatremia are associated with acute kidney injury in patients treated with cisplatin.

Louis Pinard, Jean-Philippe Adam, Miguel Chagnon

|Jan 16, 2023
Evaluation and Management of Dyslipidemia in Patients Treated with Lorlatinib.

Normand Blais, Jean-Philippe Adam, John Nguyen

|Nov 03, 2022
Management of adverse events related to first-generation tyrosine receptor kinase inhibitors in adults: a narrative review.

Christine Martineau, Maria-Kim Turcotte, Noémie Otis

|Jun 01, 2022
Cyclin-dependent kinase 4/6 inhibitor treatment use in women treated for advanced breast cancer: Integrating ASCO/NCODA patient-centered standards in a community pharmacy.

Alexandre Marineau, Catherine St-Pierre, Roxanne Lessard-Hurtubise

|Oct 15, 2021
Use of midostaurin in mixed phenotype acute leukemia with FLT3 mutation: A case series.

Zoë Tremblay, Anna Wong, Anne-Sophie Otis

|Mar 11, 2021
Successful Management of Natalizumab-Associated Primary Central Nervous System Lymphoma through Autologous Stem Cell Transplant.

Karine Moineau-Vallée, Justine Rinfret, My Hanh Luu Hoai

Pageof 2